COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 20: Articles 191-200  | Next

Epistasis between SARS-CoV-2 M and N Proteins Balances Particle Assembly and Immune Evasion
Barrera-Vasquez, A., Khalid, M. M., Ramos, H., Rosecrans, J., Ferres, M., Angulo, j., Ott, M., Taha, T. Y.
10.64898/2026.06.29.735107 — Posted: 2026-06-30
Age-dependent disease tolerance to SARS-CoV-2 infection
Trikha Rastogi, S., Mesquita, M., Fonseca, D. M., Salazar, S., Cardoso, S., Faisca, P., Drotleff, B., Alenquer, M., Lone, J.-C., Miguel, V., Sancho, D., Herrero, L., Paixao, T., Amorim, M. J., Jentho, E., Graca, L., Kitoko, J. Z., Soares, M. P.
10.64898/2026.06.27.734955 — Posted: 2026-06-30
CyStainer: A transformer-based variational autoencoder for robust marker imputation in high-parameter cytometry
Ivanov, K., Moussawy, M. A., Kirk, F., Samuli, R., Lohi, O., Olsen, L., Modvig, S., Hautamäki, V., Heinäniemi, M.
10.64898/2026.06.30.735235 — Posted: 2026-06-30
Diversifications of both the three domains of life and SARS-CoV-2 possibly driven by biases between amino acid biosynthetic families
Li, D. J.
10.64898/2026.06.22.733698 — Posted: 2026-06-30
Conversion of a Viral Glycan Shield into a Binding Anchor via Causal-Driven Antibody Optimization
Wang, X., Zhang, G., Hu, M., Han, J., Shang, C., Zhang, L., Chen, Z., Huang, P., Wang, W., Zhao, X., Dong, Y., Zhao, Y., Lv, P., Zai, X., Jin, R., Wang, H., Wei, C., Li, X., Yan, L., Lou, Z., Ren, H., Xu, J., Chi, X.
10.64898/2026.06.25.734658 — Posted: 2026-06-26
Dose optimisation of favipiravir against RNA viruses using physiologically-based pharmacokinetic modelling.
Wood, W. H., Pertinez, H., Rowland, T., Owen, A., Fletcher, T.
10.64898/2026.06.24.733995 — Posted: 2026-06-26
Coevolving Mutations in Chronic SARS-CoV-2 Infections
Hisner, R., Gupta, R. K., Martin, D.
10.64898/2026.06.11.731720 — Posted: 2026-06-25
Development of GS-441524 Derivatives as Potent SARS-CoV-2 Mac1 Inhibitors via a Direct-to-Biology Approach
Peng, K., Chakraborty, S., Wallace, S. D., Noll, J. C. G., Shang, J., Lu, X., Choi, A., Whittaker, G., Fromme, J. C., Lin, H.
10.64898/2026.06.24.734322 — Posted: 2026-06-25
DextraDemixer enables accurate identification of antigen-specific T cells from pMHC multimer experiments
An, Y., Drost, F., Bonafonte-Pardas, I., Grotz, M., Schober, K., Schubert, B.
10.64898/2026.06.23.733339 — Posted: 2026-06-25
Quantitative modeling of SARS-CoV-2 replication reveals phase-specific bottlenecks and antiviral targets
Herrmann, S. T., Kapischke, T., Westhoven, S., Heinen, N., Bertzbach, L. D., Meister, T. L., Sitek, B., Bracht, T., Pfaender, S., Kaderali, L.
10.64898/2026.06.23.733955 — Posted: 2026-06-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).